Nabiximols
GWSP19066
Phase 3 small_molecule completed
Quick answer
Nabiximols for Spasticity in Participants With Multiple Sclerosis is a Phase 3 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Spasticity in Participants With Multiple Sclerosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed